sorafenib has been researched along with Abdominal Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Azem, F; Fouks, Y; Goaz, S; Hasson, Y; Malcov, M; Sheiman, V | 1 |
Barney, BM; Bauer, HJ; Laack, NN; Macdonald, OK; Markovic, SN; Miller, RC; Olivier, KR; Sarkaria, JN | 1 |
2 other study(ies) available for sorafenib and Abdominal Neoplasms
Article | Year |
---|---|
Fertility preservation and PGT-M in women with familial adenomatous polyposis-associated desmoid tumours.
Topics: Abdominal Neoplasms; Adenomatous Polyposis Coli; Adult; Antineoplastic Agents; Female; Fertility Preservation; Fibromatosis, Aggressive; Humans; Oocyte Retrieval; Pregnancy; Preimplantation Diagnosis; Retrospective Studies; Sorafenib; Young Adult | 2021 |
Increased bowel toxicity in patients treated with a vascular endothelial growth factor inhibitor (VEGFI) after stereotactic body radiation therapy (SBRT).
Topics: Abdominal Neoplasms; Adult; Aged; Aged, 80 and over; Analysis of Variance; Antibodies, Monoclonal, Humanized; Bevacizumab; Duodenal Diseases; Humans; Indazoles; Indoles; Intestinal Diseases; Middle Aged; Niacinamide; Phenylurea Compounds; Pyrimidines; Pyrroles; Radiography; Radiosurgery; Radiotherapy Dosage; Receptors, Vascular Endothelial Growth Factor; Retrospective Studies; Sorafenib; Stomach Ulcer; Sulfonamides; Sunitinib; Ulcer | 2013 |